Weight Loss News and Research RSS Feed - Weight Loss News and Research

Cancer specialist outlines 10 symptoms that should never be ignored

Cancer specialist outlines 10 symptoms that should never be ignored

Patients often ask, "Doc, is this something to worry about?" Patients fear the worst yet often choose to ignore potentially deadly warning signs. [More]
EnteroMedics' CE Mark for Maestro System expanded to include management of Type 2 diabetes mellitus

EnteroMedics' CE Mark for Maestro System expanded to include management of Type 2 diabetes mellitus

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that its CE Mark for the Maestro Rechargeable (RC) System for obesity was expanded to include the management of Type 2 diabetes mellitus through improved glycemic control. [More]
NIH-funded clinical trial aims to restore vision in people who have lost vision due to IIH

NIH-funded clinical trial aims to restore vision in people who have lost vision due to IIH

In an NIH-funded clinical trial, led at Saint Louis University by professor of ophthalmology Sophia Chung, M.D., researchers aim to bring sight back to those who have lost vision due to idiopathic intracranial hypertension. [More]
Gastric bypass surgery provides better results than gastric banding

Gastric bypass surgery provides better results than gastric banding

Gastric bypass surgery has better outcomes than gastric banding for long-term weight loss, controlling type 2 diabetes and high blood pressure, and lowering cholesterol levels, according to a new review by UT Southwestern Medical Center surgeons of nearly 30 long-term studies comparing the two types of bariatric procedures. [More]
Australian researchers use hookworms to reduce symptoms of celiac disease

Australian researchers use hookworms to reduce symptoms of celiac disease

Australian researchers have achieved groundbreaking results in a clinical trial using hookworms to reduce the symptoms of celiac disease. [More]
Major weight loss: A risk factor for wound complications in body contouring surgery

Major weight loss: A risk factor for wound complications in body contouring surgery

Patients who lost more than 100 pounds and those who shed weight through bariatric surgery had the highest risk of complications from later surgical procedures to reshape their leaner bodies, a new study from UT Southwestern Medical Center shows. [More]
Weight cycling linked to relapse-prone bipolar course

Weight cycling linked to relapse-prone bipolar course

Patients with bipolar disorder are more likely than healthy controls to have a history of weight cycling, which in turn is associated with an increased likelihood of manic and depressive episodes, researchers report. [More]
Weight loss possible for mentally ill patients

Weight loss possible for mentally ill patients

The STRIDE lifestyle intervention helps individuals taking antipsychotics to lose weight and improve their fasting glucose levels, study findings indicate. [More]
Inovio, GeneOne to advance DNA-based Ebola vaccine into phase I clinical trial

Inovio, GeneOne to advance DNA-based Ebola vaccine into phase I clinical trial

Inovio Pharmaceuticals, Inc. announced it will advance its DNA vaccine for Ebola into a phase I clinical trial in a collaboration with GeneOne Life Science Inc., an international DNA vaccine manufacturer in which Inovio holds a minority interest. [More]
Reducing insomnia can decrease inflammation, lower risk for chronic disease in older adults

Reducing insomnia can decrease inflammation, lower risk for chronic disease in older adults

Lack of sleep can make you sick. And while everybody has the occasional restless night, for those who suffer from chronic insomnia — some 15 percent of older adults in the United States — that sleep loss can increase the risk for cardiovascular disease, hypertension, weight gain, type 2 diabetes, and even lead to an earlier death. [More]
Immune begins bertilimumab Phase II clinical trial for treatment of ulcerative colitis

Immune begins bertilimumab Phase II clinical trial for treatment of ulcerative colitis

Immune Pharmaceuticals Inc. announces today that it has initiated the screening of patients for a Phase II proof of concept clinical trial exploring the safety and efficacy of bertilimumab in the treatment of ulcerative colitis (UC). [More]
Fat mass contributes to musculoskeletal pain risk

Fat mass contributes to musculoskeletal pain risk

People with high fat mass could be at an increased risk of musculoskeletal pain, say researchers. [More]
UTMB researchers analyze whether monitors reflect practices used by health care providers

UTMB researchers analyze whether monitors reflect practices used by health care providers

Wearable electronic activity monitors hold great promise in helping people to reach their fitness and health goals. These increasingly sophisticated devices help the wearers improve their wellness by constantly monitoring their activities and bodily responses. This information is organized into companion computer programs and mobile apps. [More]
Benefits of blood pressure lowering drugs for low risk patients 'still open to question'

Benefits of blood pressure lowering drugs for low risk patients 'still open to question'

Dr Stephen Martin and colleagues argue that this strategy is failing patients and wasting healthcare resources. They call for a re-examination of the threshold and urge clinicians to be cautious about treating low risk patients with blood pressure lowering drugs. [More]
GILZ protein key to preventing bone loss, researchers report

GILZ protein key to preventing bone loss, researchers report

A small protein named GILZ appears to protect against the bone loss that often accompanies arthritis and its treatment, researchers report. [More]
FDA approves Contrave extended-release tablets for chronic weight management

FDA approves Contrave extended-release tablets for chronic weight management

Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. jointly announced today that the U.S. Food and Drug Administration has approved Contrave® extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition. [More]
Research shows potential for misunderstanding between doctors and patients about critical health issue

Research shows potential for misunderstanding between doctors and patients about critical health issue

African American women and their female children have the highest obesity prevalence of any demographic group and are more likely to underestimate their body weight than white women. [More]
Smartphones may offer better advantage of tracking diet data

Smartphones may offer better advantage of tracking diet data

Smartphones have seen wide adoption among Americans in recent years because of their ease of use and adaptability. [More]
Regular participation in physical activity may help reduce weight and treat diabetes

Regular participation in physical activity may help reduce weight and treat diabetes

A study of exercise habits in people with diabetes finds that women with diabetes who are trying to lose weight are far more physically active than women with diabetes who are not trying to control their weight. [More]
Positive outlook and support from people help diabetes patients cope with psychosocial challenges

Positive outlook and support from people help diabetes patients cope with psychosocial challenges

A positive outlook and support from people around them help patients with diabetes cope with psychosocial challenges of the disease, according to an international study that included researchers from Penn State College of Medicine. [More]